Larvol Delta - CA4948203-A-Ph2-Study-of-Emavusertib--an-Approved-BTKi-in-Patients-with-CLL-and-Other-Bcell-Malignancies

emavusertib (CA-4948) - Curis, Dr. Reddy’s

Brukinsa (zanubrutinib) - BeOne Medicines

https://euclinicaltrials.eu/ctis-public/view/2025-523600-68-00

Mar 19, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next